0.000USD0.000Pre-market 08/03, 09:30 (ET)
892.24MMarket Cap
30.81P/E TTM
Key Figures
13.150Open
13.250High
774.02KVolume
30.81P/E TTM
12.60P/E Dynamic
--Dividend TTM
1.14%Turnover Ratio
13.180Prev. Close
12.425Low
7.39MTurnover
LossP/E Static
4.72P/B
0.00%Div Yield TTM
5.15%ROA
11.24952wk High
0.98Volume Ratio
-33.54MNet Profit
67.64MShares
0.4274EPS TTM
0.69Beta
16.90%ROE
5.81052wk Low
6.26%Amplitude
67.88%Gross Margin
892.24MMarket Cap
3.95Reward/Risk
3.01%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Bioventus Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 31 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 14.80.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Bioventus Inc Highlights
StrengthsRisks
Bioventus Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Zimmer Biomet Holdings Inc
ZBH
31
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Bioventus Inc Info
Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
Ticker SymbolBVS
CompanyBioventus Inc
CEOClaypoole (Robert E)
Websitehttps://www.bioventus.com/
Shareholders
FAQs
What is the current price of Bioventus Inc (BVS)?
The current price of Bioventus Inc (BVS) is 13.17.
What is the symbol of Bioventus Inc?
The ticker symbol of Bioventus Inc is BVS.
What is the 52-week high of Bioventus Inc?
The 52-week high of Bioventus Inc is 11.25.
What is the 52-week low of Bioventus Inc?
The 52-week low of Bioventus Inc is 5.81.
What is the market capitalization of Bioventus Inc?
The market capitalization of Bioventus Inc is 892.24M.
Is Bioventus Inc (BVS) currently rated as Buy, Hold, or Sell?
According to analysts, Bioventus Inc (BVS) has an overall rating of Buy, with a price target of 14.80.
What is the Earnings Per Share (EPS TTM) of Bioventus Inc (BVS)?
The Earnings Per Share (EPS TTM) of Bioventus Inc (BVS) is 0.34.
